Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

66 -- Johnson & Johnson (J&J) Diagnostic Laboratory, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology and Blood Bank Cost-Per-Test (CPT) Reagents

Active
SP0200-05-R-5013Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Supply Center Philadelphia (DSCP) plans to establish a long-term Firm-Fixed Price Indefinite Delivery/Indefinite Quantity contract with Economic Price Adjustment provisions to provide Johnson & Johnson Ortho-Clinical Diagnostic reagents on a Cost-Per-Test (CPT) basis. These reagents cover a range of diagnostic areas including laboratory, chemistry, hematology, coagulation, urinalysis, microbiology, and blood bank testing systems used at Military Treatment Facilities worldwide. Market research confirmed that Johnson & Johnson is the sole source capable of supplying these reagents, which are specifically configured for Johnson & Johnson testing equipment already in place at these facilities. Under the CPT pricing model, Johnson & Johnson supplies equipment at no charge, and the government pays a usage fee amortized through reagent consumption, reflecting standard commercial practices. The contract requires detailed reagent catalogs, pricing tables, and supporting documentation to be submitted for each service location, with provisions for annual price adjustments based on usage and product mix changes. The contract will cover both Continental United States (CONUS) and Outside Continental United States (OCONUS) customers, with respective pricing that includes transportation and handling costs as appropriate. Delivery terms specify that CONUS pricing is FOB Destination and OCONUS pricing excludes transportation costs, which are handled by the government’s commercial carrier. Electronic commerce transactions are mandatory, utilizing the ECAT system with requirements for purchase orders, acknowledgments, confirmations, and invoicing to be conducted electronically via approved communication options. The contract term includes a one-year base period plus four unilateral one-year option periods, with an estimated total value of $35 million. Additionally, the DSCP reserves the right to add new sole source supplies post-award in compliance with competition regulations. No additional fees or costs will be allowed after award, ensuring transparency and consistency across the contract duration.

General Info

Long-term firm-fixed price contract with Johnson & Johnson for diagnostic reagents, CPT pricing, worldwide delivery.

Agency

N/A

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Various

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed. The point of contact changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Shanon A KrauseContract Specialist

Full Description

Show more
This synopsis has been modified to include the statement that Number Note 22 applies to this procurement. The Defense Supply Center Philadelphia (DSCP) intends to enter into a long-term Firm-Fixed Price (with Economic Price Adjustment) Indefinite Delivery/Indefinite Quantity (IDIQ) Contract to support the worldwide demand for Johnson & Johnson Ortho-Clinical Diagnostic Cost-Per-Test (CPT) Laboratory, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, and Blood Bank diagnostic reagents. Through Market Research it has been determined that Johnson & Johnson diagnostic reagents are specifically configured to support Johnson & Johnson's testing systems employed at the Military Treatment Facilities (MTFs) worldwide. No other manufacturer or distributor can provide the Johnson & Johnson diagnostic reagents to Continental United States (CONUS) and Outside Continental United States (OCONUS) customers on a CPT basis. It has been determined that there is only one known manufacturer, Johnson & Johnson, who has the capability of providing Johnson & Johnson CPT reagents. This solicitation will require Johnson & Johnson to submit a catalog detailing all of the diagnostic reagents for each MTF serviced. All prices for Laboratory, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, and Blood Bank diagnostic reagents must be developed based on the CPT pricing methodology. Under the CPT pricing methodology Johnson & Johnson provides the testing equipment to the individual MTF's at no cost to the government. A - usage fee to use the equipment, service and training is amortized over the reagents that are used on that equipment, which is consistent with commercial practice. Johnson & Johnson will be asked to provide tables detailing the reagents, add-on options and any additional discounts. Johnson & Johnson will be required to supply all supporting price documentation needed to determine each customer CPT price and ECAT catalog(s) with an inclusive price for each MTF serviced. The price for all reagents may be adjusted annually for those customers who did not meet the previous years annual committed usage volume or who have a change in their product mix. All increases in catalog prices charged to each customer will be recalculated using the pricing tables (e.g. reagent, add-on and discount). A price decrease can occur any time throughout the life of the contract. The DSCP reserves the right to add new Johnson & Johnson diagnostic CPT reagents and related sole source supplies on a post award basis in compliance with the requirements outlined in the Competition in Contracting Act. CONUS catalogs will include Federal facilities located in the 48 Contiguous States and the District of Columbia, as well as Alaska and Hawaii. Pricing for the CONUS catalogs will be FOB Destination inclusive of transportation, handling cost or any additional fees. OCONUS catalogs will include Federal facilities located outside the continental United States. Pricing shall be inclusive of overseas packaging costs, handling costs or any additional fees but exclusive of all transportation costs. The Government's commercial transportation carrier will be used to deliver products to OCONUS customers. After contract award, there will be no allowance for additional cost(s) or fees for any item awarded under this procurement initiative. All Purchase Order, Purchase Order Confirmation and Invoice transactions under this contract are required to be electronic. The contractor is required to use ECAT to electronically receive 850- Purchase Orders, transmit 997-Functional Acknowledgement's, send 855-Order Confirmation's, and transmit 810-Invoice's for payment. There are (2) two communication options available for ECAT; Web Supplier Interface and American National Standard Institute (ANSI) X 12 EDI Standard. Johnson & Johnson must have the capability of using at least one of these eCommerce communication options. They will be required to successfully complete system testing prior to receiving an award under this solicitation. The contract resultant from this solicitation will have a one (1) year base period with four (4) one-year unilateral option periods. This procurement has an estimated dollar value of $35,000,000.00 over the total contract period. Solicitation SP0200-05-R-5013 is expected to become available October 31, 2005 and can be found on the DLA Procurement Gateway at http://progate.daps.dla.mil/home/.

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

about 18 hours ago

DEADLINE

in 21 days
View Details
NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is seeking a qualified vendor for a one-time purchase of FDA-approved antibiotics to be stockpiled for city staff and their dependents. This procurement is intended to ensure rapid availability of medication following exposure to Category A agents, specifically anthrax, plague, or tularemia. The required deliverables include 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate/Monohydrate (100mg/dose). The purchase must be completed within the city's fiscal year ending June 30, 2027, with a strict delivery requirement of four business days from the time of order to the facility at 1845 N Fair Oaks Ave, Pasadena, CA. Vendors must adhere to rigorous CDC and industry standards for storage and handling, including cold-chain requirements and the use of temperature-monitoring devices during transit. Full lot-level traceability from production to distribution is mandatory, and all products must be accurately labeled with lot numbers, expiration dates, and manufacturer details. Bidders must be registered in SAM.gov with a Unique Entity ID and provide a Pasadena Business License. The selection process is an informal solicitation requiring electronic pricing submission via the City's eProcurement Portal by October 28, 2026. Award eligibility is contingent upon meeting insurance requirements, agreeing to Net 30 payment terms, and complying with federal regulations including the Buy America Requirement and the Davis-Bacon Act.
Public Health Department

POSTED

5 days ago

DEADLINE

in 8 days
View Details
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0116
Solicitation SPE2DP-27-T-0116 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon flavored electrolyte oral rehydration powder, identified by NSN 6505016462692. The requirement is for two packages, with each package containing 100 packets of 21 grams each. Each prepared packet provides a specific electrolyte composition consisting of 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when mixed into 16.9 fl oz of solution. The item is an over-the-counter product with a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 19, 2026. The shipping terms are FOB Destination, with the final delivery point being the USNS CODY T-EPF-14. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, while marking must adhere to Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation is associated with NAICS code 424210 and incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and requirements for safeguarding covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in about 18 hours
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS